<a href="https://laohu8.com/S/BON">Bon Natural Life</a> Ltd. Secures $18M Deal with Huahai Keyuan for Innovative Apple Series Health Products in China
Bon Natural Life Ltd. (NASDAQ: BON), a leader in the natural, health, and personal care industry, has announced an $18 million cooperation agreement with Beijing Huahai Keyuan Technology Co. Ltd., a key health products distributor in China. This 24-month, non-exclusive agreement will see Huahai Keyuan distribute BON's innovative second-generation Apple Series health products across Greater China. These products, which enhance weight management and metabolic health, leverage advanced low-temperature extraction technology to boost bioactivity by 80% compared to previous formulations. Industry analysts highlight the strong market potential, supported by consumers' growing interest in scientifically validated nutraceuticals. BON's CEO, Yongwei Hu, expressed confidence in the agreement's ability to drive significant revenue and profit growth in the nutraceutical and functional food markets.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Bon Natural Life Ltd. published the original content used to generate this news brief via PR Newswire (Ref. ID: CN68987) on September 09, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.